SDF4: A Potential Drug Target and Biomarker for Calcium Homeostasis

Target Name: SDF4

NCBI ID: G51150

SDF4: A Potential Drug Target and Biomarker for Calcium Homeostasis

Abstract:
SDF4 (45 kDa calcium-binding protein) is a protein that has been identified as a potential drug target and biomarker for calcium homeostasis. It is a member of the superfamily of Calbindin-like proteins (SCALPs), which are involved in a variety of cellular processes, including bone and muscle development, and cytoskeletal organization. SDF4 has been shown to play a critical role in the regulation of calcium homeostasis, which is a crucial aspect of many physiological processes in the body. This article will review the current literature on SDF4, including its function, structure, and potential as a drug target and biomarker.

Introduction:
Calcium homeostasis is a critical aspect of many physiological processes in the body, including muscle and bone development, nerve function, and blood clotting. The regulation of calcium homeostasis is essential for the proper functioning of these processes, and any imbalance in calcium levels can have serious consequences. One of the proteins involved in the regulation of calcium homeostasis is SDF4.

SDF4: Structure and Function:
SDF4 is a 45 kDa protein that is characterized by a unique fold. It has a single transmembrane domain and a long cytoplasmic tail that contains a variety of cytoplasmic domains, including a single calcium-binding domain (CBD) and a T-loop region. The CBD is the site of the protein's calcium binding and is responsible for the regulation of calcium homeostasis.

SDF4 is involved in the regulation of several cellular processes, including cell division, differentiation, and cytoskeletal organization. It has been shown to play a critical role in the regulation of muscle and bone development, as well as the formation of blood clots. SDF4 has also been shown to interact with several other proteins, including actinin, a protein that is involved in the regulation of cell division and the formation of actin filaments.

SDF4 as a Potential Drug Target:
SDF4 has been identified as a potential drug target due to its involvement in the regulation of calcium homeostasis. Several studies have shown that inhibitors of SDF4 can cause a decrease in the levels of calcium in cells, which can lead to a variety of cellular responses, including increased sensitivity to external stimuli, increased muscle contractions, and the formation of blood clots. These effects are consistent with the idea that SDF4 plays a critical role in the regulation of calcium homeostasis and that inhibitors of SDF4 may have therapeutic benefits in a variety of diseases.

SDF4 as a Biomarker:
SDF4 has also been shown to be a potential biomarker for a variety of diseases. Several studies have shown that SDF4 levels can be affected by a variety of factors, including stress, inflammation, and certain medications. For example, one study showed that SDF4 levels were decreased in individuals with major depressive disorder (MDD), and another study found that SDF4 levels were increased in individuals with rheumatoid arthritis (RA). These findings suggest that SDF4 may be a useful biomarker for the diagnosis and treatment of MDD and RA.

Conclusion:
SDF4 is a protein that has been identified as a potential drug target and biomarker for calcium homeostasis. Its unique fold and involvement in the regulation of cellular processes make it a promising candidate for drug development. Further research is needed to fully understand the function and potential of SDF4 in the regulation of calcium homeostasis, as well as its potential as a biomarker for a variety of diseases.

Protein Name: Stromal Cell Derived Factor 4

Functions: May regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-ER compartment

More Common Targets